BioMedNewsBreaks – Lincoln Health Network’s Upcoming Conference to Showcase Latest Innovations, Cover Every Facet of Clinical Doc Management

Lincoln Health Network, a renowned conference production company dedicated to shining a spotlight on the latest technologies and trends within the pharmaceutical, medical devices and biotech fields, today announced its plans to host the upcoming Clinical Document World conference. The event is set to take place in an entirely digital format on Feb. 24-26, 2021. The summit is designed to operate as a one-stop learning experience for life sciences professionals seeking to improve upon their clinical documentation process and will provide attendees with three days of sessions featuring faculty experienced in clinical documentation, trial master files, inspection readiness, risk management and other aspects of clinical development. The event will feature a series of more than 20 live presentations designed to encompass virtual every facet within the field of clinical document management. Experienced clinical documentation professionals will present topics including “Risk-based Approach for Document Management” by Chiesi Farmaceutici, “Successful Sponsor, CRO, and Site Collaboration” by Alexion Pharmaceuticals, “SAAS eTMF Systems Validation… Is this Really Necessary?” by Mulcahy Consulting LLC, and “Leveraging Emerging Technologies” by Daiichi Sankyo Pharma Development.

To view the full press release, visit https://ibn.fm/n0ddS

About Lincoln Health Network

Lincoln Health Network is the pharmaceutical, medical devices and life sciences go-to source for thought leadership and industry news. Research is driven through industry case studies — providing actionable data, benchmarking and insights into leading programs. Along with leading regulatory and compliance information, Lincoln Health Network’s events provide a dynamic platform for professionals to gain new education, expand networks and drive business results. Each conference, summit and workshop connects decision makers with peer networking, technology solutions and cutting-edge, peer-driven content. To learn more, visit: www.LincolnHealthNetwork.com

About BioMedWire

BioMedWire (BMW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) BioMedNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. BMW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information please visit https://www.biomedwire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.biomedwire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is part of the InvestorBrandNetwork

Chris@BMW

Share
Published by
Chris@BMW

Recent Posts

BioMedNewsBreaks – TransCode Therapeutics, Inc. (NASDAQ: RNAZ) Submits IND Amendment for Planned Phase 2a Trial of TTX-MC138 in Colorectal Cancer

TransCode Therapeutics (NASDAQ: RNAZ) announced the submission of an Investigational New Drug ("IND") application amendment…

1 day ago

BioMedNewsBreaks – Telomir Pharmaceuticals (NASDAQ: TELO) Reports New Cellular Data Demonstrating Coordinated Intracellular Zinc Increase and Iron Reduction With Telomir-Zn

Telomir Pharmaceuticals (NASDAQ: TELO) announced new cellular study results showing that Telomir-1, administered as Telomir-Zn,…

1 day ago

BioMedNewsBreaks – Oragenics Inc. (NYSE American: OGEN) Engages DUCK FLATS Pharma for IND Readiness and Regulatory Execution

Oragenics (NYSE American: OGEN) announced that it has engaged DUCK FLATS Pharma as its U.S.…

3 days ago

BioMedNewsBreaks – Oragenics Inc. (NYSE American: OGEN) Participates in SCOPE Summit 2026 Ahead of Phase 2a Concussion Trial

Oragenics (NYSE American: OGEN), a clinical-stage biotechnology company developing intranasal therapeutics for neurological disorders, announced…

4 days ago

BioMedNewsBreaks – NanoViricides (NYSE American: NNVC) Highlights Mission Matters Podcast Interview With President Anil Diwan

NanoViricides, Inc. (NYSE American: NNVC) announced that President Dr. Anil R. Diwan was interviewed on…

4 days ago

BioMedNewsBreaks — VolitionRx (NYSE American: VNRX) Prepares Reimbursement Submission for Nu.Q Cancer Assays in France

VolitionRx Ltd. (NYSE American: VNRX) (“Volition”), a multi-national epigenetics company, announced that it is preparing a reimbursement submission for its Nu.Q®…

7 days ago